Skip to content Skip to footer
Close
team-Francisco

M.D.

Dr. Gerard E. Francisco

Professor Gerard Francisco is co-chair of the Toxnet group. He is one of the United States’ leading physicians in the field of brain injury and stroke rehabilitation and spasticity management. A frequent lecturer nationally and internationally.

United States

Biography

Chief Medical Officer, TIRR Memorial Hermann

Professor and Chairman of Physical Medicine and Rehabilitation at McGovern Medical School at The University of Texas Health Science Center at Houston (UTHealth)

Dr. Francisco is one of the United States’ leading physicians in the field of brain injury and stroke rehabilitation and spasticity management. A frequent lecturer nationally and internationally, he is currently conducting research on the use of botulinum toxin and intrathecal baclofen for the treatment of spasticity, along with the use of robots to facilitate recovery after a stroke or spinal cord injury. Dr. Francisco is a Principal investigator in an R01 grant from the National Institutes of Health.

Dr. Francisco is chairman and clinical professor in the Department of Physical Medicine and Rehabilitation (PM&R) at The University of Texas Medical School at Houston and adjunct professor at Baylor College of Medicine. He received his medical degree from the University of the Philippines and completed his internship at Michael Reese Hospital in Chicago. His residency in PM&R was at the University of Medicine and Dentistry-New Jersey Medical School, where he was chief resident. Dr. Francisco completed a postdoctoral fellowship in Brain Injury Rehabilitation at Baylor College of Medicine.

Before joining the Brain Injury Program at TIRR Memorial Hermann in 1997, he served as director of the Brain Injury Program at Kessler Institute for Rehabilitation and assistant professor in the department of Physical Medicine and Rehabilitation at New Jersey Medical School.

Dr. Francisco was named Distinguished Educator Professor by University of Texas Medical School at Houston “Academy of Master Educators” in 2012 and inducted as a member of the University of Texas Academy of Health Science Education (2013). Dr. Francisco was elected to “Best Doctors in America” for 2007-2008 by his peers. From 2001-2012, he has been listed in “Best Doctors in America” by U.S. World & News Report. In 2013, he was nominated by his peers to Houstonia Magazine’s list of Top Doctors.

Other team members

team-balbert

Dr. Alexander Balbert

team-baricich

Prof. Alessio Baricich

team-bensmail

Prof. Djamel Bensmail

team-Bianchi

Dr.ssa. Francesca Bianchi

team-biering-sorenson

Dr. Bo Biering-Sørensen

team-carda

Dr. Stefano Carda

team-deltombe2

Prof. Thierry Deltombe

team-draulans

Dr. Nathalie Draulans

team-escaldi

Dr. Steven V. Escaldi

team-Gross

Prof. Raphaël Johannes Gross

team-JACINTO-teste

Dr. Luis Jorge Jacinto

team-molteni

Dr. Franco Molteni

team-odell

Prof. Michael O’Dell

team-Picelli

Prof. Alessandro Picelli

team-reebye

Prof. Rajiv Reebye

team-Santamato-2

Prof. Andrea Santamato

team-verduzco

Prof. Monica Verduzco-Gutierrez

team-walker

Dr. Heather Walker

team-wissel

Prof. Jörg Wissel

team-zimmerman

Dr. Maximo Zimerman

Brenda McCleary, an independent consultant, provides general management and scientific support for Toxnet projects.

© 2024 ToxNet. All Rights Reserved.

Supported by Merz Therapeutics GmbH

Liability for links
Our site contains links to external websites, over which we have no control. Therefore we cannot accept any responsibility for this external content. The respective provider or operator is always responsible for the contents of any linked site. At the time of linking the linked sites where checked for possible legal violations. At the time of linking illegal contents were not indicated. A permanent control of the linked pages is unreasonable without concrete evidence of violation. Upon notification of violations, we will remove such links immediately.

Award scoring criteria

The following criteria will be judged out of a score of 5; (1 is suboptimal; 2 is adequate; 3 is good; 4 is very good; 5 is excellent)

GENERAL

  • Days per week working in spasticity management
  • Average number of spasticity patients managed per month
  • Environment and clinical team (type of institution, location, size/structure of clinical team, particular patient needs)
  • Role of responsibility in managing patients with spasticity
  • Scientific appointments in spasticity
  • Honours for work undertaken in spasticity

SCHOLARLY

  • Number of research projects investigating relevant aspects of spasticity management
  • Impact of research projects investigating relevant aspects of spasticity management
  • Number of peer-reviewed publications on topic
    Number of presentations of research at international meetings
  • Number of presentations at national conferences
  • Teaching/mentorship of younger injectors
  • h-index

CLINICAL

  • Evidence of development or growth of a spasticity program at the applicant’s practice or institution
  • Breadth of services provided, including medications, toxins, physical interventions, and Intrathecal Baclofen Therapy (ITB)
  • Role of responsibility in managing patients with spasticity

ENDORSEMENT

  • Endorsed by senior peer

In the event of a tie, based on the above scoring criteria, the Toxnet Co-Chairs will make the final decision.